PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
We are achieving the target of developed India by making our young children healthy today
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
Launches collaborative centre for translational research in head and neck cancer
Subscribe To Our Newsletter & Stay Updated
